Oncolytics Biotech Valuation
ONC Stock | CAD 1.38 0.02 1.43% |
Today, the company appears to be overvalued. Oncolytics Biotech holds a recent Real Value of C$1.21 per share. The prevailing price of the company is C$1.38. Our model determines the value of Oncolytics Biotech from analyzing the company fundamentals such as Shares Outstanding of 75.42 M, return on equity of -1.03, and Shares Owned By Institutions of 6.98 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support obtaining undervalued entities and abandoning overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Price Book 3.7761 | Enterprise Value 69.6 M | Enterprise Value Ebitda (2.08) |
Overvalued
Today
Please note that Oncolytics Biotech's price fluctuation is extremely dangerous at this time. Calculation of the real value of Oncolytics Biotech is based on 3 months time horizon. Increasing Oncolytics Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Oncolytics Biotech is useful when determining the fair value of the Oncolytics stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Oncolytics Biotech. Since Oncolytics Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oncolytics Stock. However, Oncolytics Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.38 | Real 1.21 | Hype 1.37 | Naive 1.34 |
The real value of Oncolytics Stock, also known as its intrinsic value, is the underlying worth of Oncolytics Biotech Company, which is reflected in its stock price. It is based on Oncolytics Biotech's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Oncolytics Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Oncolytics Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Oncolytics Biotech helps investors to forecast how Oncolytics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oncolytics Biotech more accurately as focusing exclusively on Oncolytics Biotech's fundamentals will not take into account other important factors: Oncolytics Biotech Investments |
|
Oncolytics Biotech Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Oncolytics Biotech's current stock value. Our valuation model uses many indicators to compare Oncolytics Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oncolytics Biotech competition to find correlations between indicators driving Oncolytics Biotech's intrinsic value. More Info.Oncolytics Biotech is regarded second in beta category among related companies. It is regarded fifth in net asset category among related companies making up about 26,141,414 of Net Asset per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Oncolytics Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Oncolytics Biotech's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oncolytics Biotech's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Oncolytics Biotech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Oncolytics Biotech and how it compares across the competition.
About Oncolytics Biotech Valuation
The stock valuation mechanism determines the current worth of Oncolytics Biotech on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Oncolytics Biotech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Oncolytics Biotech based exclusively on its fundamental and basic technical indicators. By analyzing Oncolytics Biotech's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Oncolytics Biotech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncolytics Biotech. We calculate exposure to Oncolytics Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oncolytics Biotech's related companies.Last Reported | Projected for 2024 | ||
Gross Profit | 0.00 | 0.00 | |
Pretax Profit Margin | (6.74) | (7.08) | |
Operating Profit Margin | (6.81) | (7.15) | |
Net Loss | (6.75) | (7.08) | |
Gross Profit Margin | 0.00 | 0.00 |
8 Steps to conduct Oncolytics Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Oncolytics Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Oncolytics Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Oncolytics Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Oncolytics Biotech's revenue streams: Identify Oncolytics Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Oncolytics Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Oncolytics Biotech's growth potential: Evaluate Oncolytics Biotech's management, business model, and growth potential.
- Determine Oncolytics Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Oncolytics Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.Note that the Oncolytics Biotech information on this page should be used as a complementary analysis to other Oncolytics Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Oncolytics Stock analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
CEOs Directory Screen CEOs from public companies around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |